Zi-jun Xu

1Department Of Hematology, 8 Dianli Rd
Zhenjiang, 212002, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

The Clinical Significance of ARHGAP10 Alterations in Acute Myeloid Leukemia

The Clinical Significance of ARHGAP10 Alterations in Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 03, 2026

Comprehensive characterization of VSIR reveals dual epigenetic regulation and immune landscape across hematological malignancies.

Comprehensive characterization of VSIR reveals dual epigenetic regulation and immune landscape across hematological malignancies.

Journal: Scientific reports

Published: December 19, 2025

A rare cytogenetically cryptic MECOM rearrangement in a patient with myelodysplastic neoplasm and SF3B1 mutation identified by RNA sequencing: a case report.

A rare cytogenetically cryptic MECOM rearrangement in a patient with myelodysplastic neoplasm and SF3B1 mutation identified by RNA sequencing: a case report.

Journal: Frontiers in oncology

Published: November 08, 2025

Molecular international prognostic index prognostic model in diffuse large B-cell lymphoma.

Molecular international prognostic index prognostic model in diffuse large B-cell lymphoma.

Journal: Discover oncology

Published: November 01, 2025

Distinctive Molecular Risk Factors Between MDS and MDS/AML Defined by ICC.

Distinctive Molecular Risk Factors Between MDS and MDS/AML Defined by ICC.

Journal: American journal of hematology

Published: October 13, 2025

Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia.

Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia.

Journal: Frontiers in immunology

Published: September 20, 2025

Clinical Significance of CD109 Expression and Methylation Patterns in Acute Myeloid Leukemia.

Clinical Significance of CD109 Expression and Methylation Patterns in Acute Myeloid Leukemia.

Journal: Clinical laboratory

Published: August 08, 2025

Expression and Clinical Significance of lncRNA NCK1-AS1 in Acute Myeloid Leukemia

Expression and Clinical Significance of lncRNA NCK1-AS1 in Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: May 06, 2025

MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells.

MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells.

Journal: Cell biochemistry and biophysics

Published: March 07, 2025

FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies.

FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies.

Journal: Frontiers in immunology

Published: February 01, 2025

Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia.

Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia.

Journal: BMC cancer

Published: October 16, 2024

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity.

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity.

Journal: Frontiers in immunology

Published: August 07, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026